The Discounted Cash Flow (DCF) valuation of Eagle Pharmaceuticals Inc (EGRX) is 38.95 USD. With the latest stock price at 2.14 USD, the upside of Eagle Pharmaceuticals Inc based on DCF is 1720.3%.
Based on the latest price of 2.14 USD and our DCF valuation, Eagle Pharmaceuticals Inc (EGRX) is a buy. buying EGRX stocks now will result in a potential gain of 1720.3%.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 7.6% | 6.8% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 32.12 - 49.53 | 38.95 |
| Upside | 1401.0% - 2214.6% | 1720.3% |